HOME >> BIOLOGY >> NEWS
Jefferson researchers' discovery may change thinking on how viruses invade the brain

(PHILADELPHIA) -- A molecule thought crucial to ferrying the deadly rabies virus into the brain, where it eventually kills, apparently isnt. The surprising finding, say researchers at Jefferson Medical College in Philadelphia, may change the way scientists think about how central nervous system-attacking viruses such as herpes viruses invade the brain and cause disease.

According to Matthias Schnell, Ph.D., professor of microbiology and immunology at Jefferson Medical College of Thomas Jefferson University, viruses such as rabies must be actively transported to the brain and central nervous system. The LC8 protein was thought to tether viruses to the cellular transport machinery in order to get there.

But Dr. Schnell and his co-workers found that this protein complex is instead a "transcription factor" that plays a role in virus reproduction. "We think that this finding has implications not only for rabies but many viruses that previously were thought to use this complex for transport, such as herpes viruses," he says. They report their results online this week in the journal Proceedings of the National Academy of Sciences.

To understand the role of LC8 in rabies disease in the brain, the team compared a rabies virus strain with the LC8 "binding domain" (where the rabies virus and LC8 protein interact) to a virus lacking it. They showed that in mice that were infected with rabies without the LC8 binding domain, the virus was still able to infect the brain, but did not cause disease. The virus ability to reproduce was greatly diminished.

"What we found has nothing to do with transport," Dr. Schnell says. "We saw that the virus was weakened if we removed the LC8 binding site and viral replication and transcription were affected. But we didnt find a difference in the initial viral entry in the central nervous system. We actually saw that the virus replicated better with the binding site than without it. LC8 is a transcripti
'"/>

Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University
19-Apr-2007


Page: 1 2

Related biology news :

1. Jefferson scientists patent dramatically improves
2. Marker predicts pancreatic cancer outcome after surgery, Jefferson surgeon finds
3. Tiny genes may increase cancer susceptibility, Jefferson scientists find
4. Jefferson scientists use gene therapy to reverse heart failure in animals
5. Jefferson scientists identify protein key to breast cancer spread, potential new drug target
6. Jefferson scientists find rabies-based vaccine could be effective against HIV
7. Jefferson scientists uncover gene mutation that cuts colon polyps, may suppress cancer
8. Targeting the adrenal gland could be key strategy against heart failure, Jefferson scientists show
9. Jefferson scientists find guardian genes choices crucial to stopping cancer process
10. Jefferson researchers uncover new way nature turns genes on and off
11. Jefferson researchers develop combined procedure for uterine preservation in treating fibroids

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/27/2018)... , ... November 27, 2018 , ... ... cryogenics industry a sealing solution with a broader range of usage temperature compared ... PEEK expert will introduce its new VICTREX CT™ 200 for dynamic sealing applications ...
(Date:11/23/2018)... FRANCISCO (PRWEB) , ... November 23, 2018 , ... ... of Dr. Emeran Mayer, MD, Executive Director of the G. Oppenheimer Center for ... of leading scientists and doctors from around the world, Dr. Mayer will bring ...
(Date:11/20/2018)... ... November 19, 2018 , ... ... Bay Area -- the first and only non-invasive buttock lift procedure, with no ... cleared to strengthen, tone and firm the buttocks to provide a safe and ...
Breaking Biology News(10 mins):
(Date:11/9/2018)... ... November 08, 2018 , ... ... States, adopted a machine-learning powered approach to increasing recovery rates by creating a ... Artificially Intelligent Collections (AIC) product developed by NLP Logix, a Jacksonville, Florida-based AI ...
(Date:11/6/2018)... (PRWEB) , ... November 06, 2018 , ... ... mobile app for clinical trial data collection and management. TrialKit ™, an ... with compatible generation devices can quickly and easily sign in to the app ...
(Date:11/5/2018)... ... November 05, 2018 , ... 2Blades has completed a non-exclusive ... effector code technology for applications in advancing research in epigenetic technology. , ... discovery in 2009, the efficacy of TAL effector-based DNA targeting has been established ...
(Date:10/31/2018)... ... 2018 , ... Myoscience, Inc. announced today that it has ... Tennessee. This study enrolled 125 patients and compares the effect of cryoanalgesia ... total knee replacement surgery (TKA). , The Myoscience iovera° system is currently being ...
Breaking Biology Technology:
Cached News: